Geisinger Cancer Institute Attains National Reaccreditation

Geisinger Cancer Institute has received reaccreditation under the American College of Surgeons (ACS) Commission on Cancer (CoC) Accreditation Program at Geisinger Community Medical Center in Scranton.

The ACS CoC is a consortium of professional organizations dedicated to improving survival and quality of life for patients with cancer by setting and raising standards. 

“As the population in the northeast continues to age, with that comes the need for high-quality cancer care close to home,” said Erin Miller, D.O., a Geisinger general surgeon and ACS CoC committee chair. “Our recognition by the ACS CoC signifies that we meet the rigorous standards required to deliver exceptional care to our patients and validates our efforts while enabling us to further elevate the standards of cancer care in our region.”

CoC accreditation is granted to institutions committed to providing high-quality cancer care by demonstrating compliance with the CoC standards. Each program must undergo a rigorous evaluation and review of its performance and compliance with the CoC standards. To maintain accreditation, cancer programs must undergo a site visit every three years. The CoC accreditation standards supply the structure for providing all patients with a full range of diagnostic, treatment and supportive services either on site or by referral, including community-based resources.

As a CoC-accredited institution, Geisinger also becomes an ACS Surgical Quality Partner, which means it is dedicated to consistently improving procedures and approaches, while maintaining a critical eye on process at every step.

“ACS Quality programs are grounded in more than a century of experience and participation is an important measure of a hospital’s surgical quality. As an ACS Surgical Quality Partner, Geisinger has shown a commitment to providing the best possible patient care, evaluating that care in a rigorous fashion and dedicating themselves to continuous self-improvement,” said Patricia L. Turner, M.D., executive director and chief executive officer of ACS.